Michael Karl Bauer is a highly accomplished senior biotech professional with extensive experience in academic research, preclinical and clinical development. They currently serve as a Partner at Novo Holdings Venture Investments and hold board positions at AvenCell, Myricx Bio, and Numab Therapeutics AG. Having previously held leadership roles at Genmab, BankInvest, and Novo Nordisk, they have successfully guided teams through various stages of drug development, showcasing their strong leadership and communication skills. Michael earned a PhD in Agriculture from The University of Göttingen and continues to enhance their expertise through ongoing education at IMD Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices